Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
W91YTV10F0041
Contract
Obligated and Ceiling
- Obligated (net)
- $2,005,574.69
- Ceiling (potential value, not spending)
- $2,483,988.73
- Current value
- $2,005,574.69
- Gross positive obligations
- $2,005,574.69
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- JOHNSON & JOHNSON HEALTHCARE · LKV3QN1ND7D1
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTV
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTV10F0041
- Parent vehicle (IDV PIID)
- V797P7126A
- Award type code
- C
- Actions
- 9 · Apr 1, 2010 to Dec 12, 2012
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 12, 2012 | FY2013 | P00009 | C | $567,000.00 | — |
| Apr 16, 2012 | FY2012 | P00008 | C | $12,008.64 | — |
| Mar 7, 2012 | FY2012 | P00007 | D | $22,168.90 | — |
| Dec 5, 2011 | FY2012 | P00006 | C | $558,110.99 | — |
| Sep 22, 2011 | FY2011 | P00005 | D | $8,979.82 | — |
| Dec 8, 2010 | FY2011 | P00004 | C | $478,414.04 | — |
| Jun 28, 2010 | FY2010 | P00003 | M | $0.00 | — |
| Jun 7, 2010 | FY2010 | P00001 | D | $303.05 | — |
| Apr 1, 2010 | FY2010 | 0 | — | $358,589.25 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.